Lack of specificity of anticyclic citrullinated peptide antibodies in advanced human immunodeficiency virus infection

Journal of Rheumatology

Volumn 38, Issue 6, 2011, Pages 1055-1060

  Du Toit, Riëtte ^a   Whitelaw, David ^a   Taljaard, Jantjie J ^b   Du Plessis, Lisa ^a   Esser, Monika ^c  

^a Division of Rheumatology   (South Africa)

^b Division of Infectious Diseases   (South Africa)

^c STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

Anticyclic citrullinated peptide antibodies; Human immunodeficiency virus; Rheumatoid arthritis; Rheumatoid factor

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; RHEUMATOID FACTOR;

ADULT; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

ADULT; ANTIBODIES; ANTIBODY SPECIFICITY; ANTIGENS, CD4; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PEPTIDES, CYCLIC; PREVALENCE; RHEUMATIC FEVER; RHEUMATOID FACTOR; SOUTH AFRICA;

EID: 79957807453     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.100713     Document Type: Article

References (31)

1. Medina F, Pérez-Saleme L, Moreno J. Rheumatic manifestations of human immunodeficiency virus infection. Infect Dis Clin N Am 2006;20:891-912. (Pubitemid 44752021)
2. Cuellar ML, Espinoza LR. Rheumatic manifestations of HIV-AIDS. Baillieres Best Pract Res Clin Rheumatol 2000;14:579-93.
3. Reveille JD. Rheumatic manifestations of human immunodeficiency virus infection. In: Ruddy S, Harris ED, Sledge CB, editors. Kelley's textbook of rheumatology. 7th ed. Philadelphia: WB Saunders; 2005:1661-73.
4. Bijlsma JW, Derksen RW, Huber-Bruning O, Borleffs JC. Does AIDS "cure" rheumatoid arthritis? Ann Rheum Dis 1988;47:350-1.
5. Zandman-Goddard G, Shoenfeld Y. HIV and autoimmunity. Autoimmun Rev 2002;1:329-37. (Pubitemid 38340245)
6. Massabki PS, Accetturi C, Nishie IA, da Silva NP, Sato EI, Andrade LE. Clinical implications of autoantibodies in HIV infection. AIDS 1997;11:1845-50. (Pubitemid 27500961)
7. Procaccia S, Lazzarin A, Colluci A, Gasparini A, Forcellini P, Lanzanova D, et al. IgM, IgG and IgA rheumatoid factors and circulating immune complexes in patients with AIDS and AIDS-related complex with serological abnormalities. Clin Exp Immunol 1987;67:236-44.
8. Zendman AJ, van Venrooij WJ, Pruijn GJ. Use and significance of anti-CCP autoantibodies in rheumatoid arthritis. Rheumatology 2006;45:20-5. (Pubitemid 43033869)
9. Mutlu N, Bicakcigil M, Tasan DA, Kaya A, Yavuz S, Ozden I. Comparative performance analysis of 4 different anti-citrullinated protein assays in the diagnosis of rheumatoid arthritis. J Rheumatol 2009;36:491-500.
10. Nishimura K, Sugiyama D, Kogata Y, Tsuji G, Nakazawa T, Kawano S, et al. Meta-analysis: Diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis. Ann Intern Med 2007;146:797-808. (Pubitemid 351650500)
11. Avouac J, Gossec L, Dougados M. Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review. Ann Rheum Dis 2006;65:845-51.
12. Midiwake R, Isenberg DA, Schellekens GA, van Venrooij WJ. Use of anti-citrullinated peptide and anti-RA 33 antibodies in distinguishing erosive arthritis in patients with systemic lupus erythematosus and rheumatoid arthritis. Ann Rheum Dis 2001;60:67-8. (Pubitemid 32038957)
13. Gottenberg JE, Mignot S, Nicaise-Rolland P, Cohen-Solal J, Aucouturier F, Goetz J, et al. Prevalence of anti-cyclic citrullinated peptide and anti-keratin antibodies in patients with primary Sjögren's syndrome. Ann Rheum Dis 2005;64:114-7. (Pubitemid 40075286)
14. Vander Cruyssen B, Hoffman IE, Zmierczak H, Van den Berghe M, Kruithof E, De Rycke L, et al. Anti-citrullinated peptide antibodies may occur in patients with psoriatic arthritis. Ann Rheum Dis 2005;64:1145-9. (Pubitemid 41113348)
15. Wener MM, Hutchinson K, Morishima C, Gretch DR. Absence of antibodies to cyclic citrullinated peptide in sera of patients with hepatitis C infection and cryoglobulinemia. Arthritis Rheum 2004;50:2305-8. (Pubitemid 38924410)
16. Bombardieri M, Allessandri C, Labbadia G, Iannuccelli C, Carlucci F, Riccieri V, et al. Role of anti-cyclic citrullinated peptide antibodies in discriminating patients with rheumatoid arthritis from patients with chronic hepatitis C infection-associated polyarticular involvement. Arthritis Res Ther 2004;6:R137-41.
17. Lim MK, Sheen DH, Lee YR, Mun YR, Park M, Shim SC. Anti-cyclic citrullinated peptide antibodies distinguish hepatitis B virus (HBV)-associated arthropathy from concomitant rheumatoid arthritis in patients with chronic HBV infection. J Rheumatol 2009;36:712-6.
18. Bizarro N. Antibodies to citrullinated peptides: a significant step forward in the early diagnosis of rheumatoid arthritis. Clin Chem Lab Med 2007;45:150-7.
19. South African Department of Health, 2009. 2008 National Antenatal Sentinel HIV and Syphilis Prevalence Survey, South Africa. [Internet. Accessed January 6, 2011.] Available from: http://www.info.gov.za/view/ DownloadFileAction?id=109007
20. World Health Organisation. Interim WHO clinical staging of HIV/AIDS and HIV/AIDS case definitions for surveillance; African region. Geneva: WHO Press; 2005. [Internet. Accessed January 6, 2011.] Available from: http://www.who.int/ hiv/pub/guidelines/clinicalstaging.pdf
21. South African National Department of Health. National antiretroviral treatment guidelines, 1st edition 2004; section 1. [Internet. Accessed January 6, 2011.] Available from: http://www.doh.gov.za/docs/hivaids-progressrep.html
22. French MA, Mallal SA, Dawkins RL. Zidovidine-induced restoration of cell-mediated immunity to mycobacteria in immunodeficient HIV-infected patients. AIDS 1992;6:1293-7.
23. Elkayam O, Segal R, Lidgi M, Caspi D. Positive anti-cyclic citrullinated proteins and rheumatoid factor during active lung tuberculosis. Ann Rheum Dis 2006;65:1110-2. (Pubitemid 44133278)
24. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
25. Fernandez-Miranda C, Rubio R, Pulido F. Development of acquired immunodeficiency syndrome in a patient with SLE. J Rheumatol 1995;22:347.
26. Wegrzyn J, Livrozet JM, Touraine JL, Miossec P. Rheumatoid arthritis after 9 years of human immunodeficiency virus infection: possible contribution of tritherapy. J Rheumatol 2002;29:2232-4.
27. Diri E, Lipsky PE, Berggren RE. Emergence of systemic lupus erythematosus after initiation of highly active antiretroviral therapy for human immunodeficiency virus infection. J Rheumatol 2000;27:2711-4.
28. Leonard H, Calabrese DO, Kirchner E, Shrestha R. Rheumatic complications of human immunodeficiency virus infection in the era of highly active anti-retroviral therapy. Emergence of a new syndrome of immune reconstitution and changing patterns of disease. Semin Arthritis Rheum 2005;35:166-74.
29. Nielen MM, van Schaardenburg D, Reesink HW, van de Stadt RJ, van der Horst-Bruinsma IE, de Koning MH, et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum 2004;50:380-6. (Pubitemid 38198821)
30. Rantapää-Dahlqvist S, de Jong BA, Berglin E, Hallmans G, Wadell G, Stenlund H, et al. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 2003;48:2741-9. (Pubitemid 37280601)
31. Chibnik LB, Mandl LA, Costenbader KH, Schur PH, Karlson EW. Comparison of threshold cutpoints and continuous measures of anti-cyclic citrullinated peptide antibodies in predicting future rheumatoid arthritis. J Rheumatol 2009;36:706-11.